A new class of weight loss drugs known as GLP-1s, like Wegovy and Zepbound, helped grow the weight loss industry to nearly $90 billion last year. Now, weight loss companies, apps and fitness companies are adapting their to programs include the drugs, as well. Also, allegations of serious fraud threaten a big U.S.-U.K. soccer deal, and China’s latest trade data showed a return to growth in April.

Support our nonprofit newsroom today and pick up a fun thank-you gift like our new Shrinkflation mini tote bag or the fan favorite KaiPA pint glass!